Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Abstract:

:Human fibrinogen 1 is homodimeric with respect to its gamma chains (gammaA-gammaA'), whereas fibrinogen 2 molecules each contain one gammaA (gammaA1-411V) and one gamma' chain, which differ by containing a unique C-terminal sequence from gamma'408 to 427L that binds thrombin and factor XIII. We investigated the structural and functional features of these fibrins and made several observations. First, thrombin-treated fibrinogen 2 produced finer, more branched clot networks than did fibrin 1. These known differences in network structure were attributable to delayed release of fibrinopeptide (FP) A from fibrinogen 2 by thrombin, which in turn was likely caused by allosteric changes at the thrombin catalytic site induced by thrombin exosite 2 binding to the gamma' chains. Second, cross-linking of fibrin gamma chains was virtually the same for both types of fibrin. Third, the acceleratory effect of fibrin on thrombin-mediated XIII activation was more prominent with fibrin 1 than with fibrin 2, and this was also attributable to allosteric changes at the catalytic site induced by thrombin binding to gamma' chains. Fourth, fibrinolysis of fibrin 2 was delayed compared with fibrin 1. Altogether, differences between the structure and function of fibrins 1 and 2 are attributable to the effects of thrombin binding to gamma' chains.

journal_name

Blood

journal_title

Blood

authors

Siebenlist KR,Mosesson MW,Hernandez I,Bush LA,Di Cera E,Shainoff JR,Di Orio JP,Stojanovic L

doi

10.1182/blood-2005-01-0240

subject

Has Abstract

pub_date

2005-10-15 00:00:00

pages

2730-6

issue

8

eissn

0006-4971

issn

1528-0020

pii

2005-01-0240

journal_volume

106

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist.

    abstract::Previous results have demonstrated that anti-D therapy in children with chronic auto-immune thrombocytopenic purpura (AITP) induced a significant increase in several pro- and anti-inflammatory plasma cytokines within 2 hours of administration. To investigate the biologic basis of these early in vivo responses, we deve...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1029

    authors: Coopamah MD,Freedman J,Semple JW

    更新日期:2003-10-15 00:00:00

  • Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study.

    abstract::Interphase cytogenetics by means of in situ hybridization with the chromosome 12-specific biotinylated alpha satellite DNA probe pSP 12-1 was used for the study of trisomy 12, the most common chromosomal abnormality in chronic lymphocytic leukemia. In situ hybridization was performed on methanol/acetic acid fixed cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Losada AP,Wessman M,Tiainen M,Hopman AH,Willard HF,Solé F,Caballín MR,Woessner S,Knuutila S

    更新日期:1991-08-01 00:00:00

  • Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.

    abstract::Fibrin deposition and platelet thrombus dimensions on subendothelium were studied in four groups of patients with coagulation factor deficiencies. Five patients with factor VIII deficiency (APTT 120 +/- 8 sec) and three patients with factor IX deficiency (APTT 125 +/- 11 sec) were severe bleeders, whereas four patient...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weiss HJ,Turitto VT,Vicic WJ,Baumgartner HR

    更新日期:1984-05-01 00:00:00

  • Alloantibodies in von Willebrand disease.

    abstract::The development of alloantibodies against von Willebrand factor (VWF) represents a rare but serious complication of treatment of von Willebrand disease (VWD), occurring in ~5% to 10% of type 3 VWD patients. Affected patients can present with a range of symptoms, including lack or loss of hemostatic response to infused...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-10-462085

    authors: James PD,Lillicrap D,Mannucci PM

    更新日期:2013-08-01 00:00:00

  • Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli.

    abstract::Neurotrophins, such as nerve growth factor (NGF) and neurotrophin-3 (NT-3), are essential for development, function, and survival of peripheral sympathetic and sensory neurons. Most eosinophilic leukocytes in the human body are localized in mucosal tissues; however, the roles of eosinophils in human diseases are not f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.6.2214

    authors: Kobayashi H,Gleich GJ,Butterfield JH,Kita H

    更新日期:2002-03-15 00:00:00

  • Separation of erythroid progenitor cells in mouse bone marrow by isokinetic-gradient sedimentation.

    abstract::Isokinetic-gradient sedimentation employing a shallow linear gradient of Ficoll in tissue culture medium was used to isolate erythroid progenitor cells (CFU-e) from mouse bone marrow. Following gradient sedimentation, 34% of the total nucleated cells and 48% of the CFU-e applied to the gradient were recovered, and thr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Misiti J,Spivak JL

    更新日期:1979-07-01 00:00:00

  • Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.

    abstract::Prior studies have reported high response rates with recombinant interferon-α (rIFN-α) therapy in patients with essential thrombocythemia (ET) and polycythemia vera (PV). To further define the role of rIFN-α, we investigated the outcomes of pegylated-rIFN-α2a (PEG) therapy in ET and PV patients previously treated with...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood.2019000428

    authors: Yacoub A,Mascarenhas J,Kosiorek H,Prchal JT,Berenzon D,Baer MR,Ritchie E,Silver RT,Kessler C,Winton E,Finazzi MC,Rambaldi A,Vannucchi AM,Leibowitz D,Rondelli D,Arcasoy MO,Catchatourian R,Vadakara J,Rosti V,Hexner E

    更新日期:2019-10-31 00:00:00

  • Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

    abstract::Pim kinases are involved in B-cell development and are overexpressed in B-cell chronic lymphocytic leukemia (CLL). We hypothesized that Pim kinase inhibition would affect B-cell survival. Identified from a screen of imidazo[1,2-b]pyridazine compounds, SGI-1776 inhibits Pim-1, Pim-2, and Pim-3. Treatment of CLL cells w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-212852

    authors: Chen LS,Redkar S,Bearss D,Wierda WG,Gandhi V

    更新日期:2009-11-05 00:00:00

  • Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production.

    abstract::Nitric oxide (NO) is a potent radical produced by nitric oxide synthase (NOS) and has pleiotrophic activities in health and disease. As mast cells (MCs) play a central role in both homeostasis and pathology, we investigated NOS expression and NO production in human MC populations. Endothelial NOS (eNOS) was ubiquitous...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2990

    authors: Gilchrist M,McCauley SD,Befus AD

    更新日期:2004-07-15 00:00:00

  • A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.

    abstract::Ibrutinib is highly efficacious and used at 420 mg/d for treatment of chronic lymphocytic leukemia (CLL). We previously demonstrated a decline in Bruton's tyrosine kinase (BTK) protein levels in CLL cells after 1 cycle of ibrutinib, suggesting ibrutinib dose could be lowered after the first cycle without loss of biolo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2018-06-860593

    authors: Chen LS,Bose P,Cruz ND,Jiang Y,Wu Q,Thompson PA,Feng S,Kroll MH,Qiao W,Huang X,Jain N,Wierda WG,Keating MJ,Gandhi V

    更新日期:2018-11-22 00:00:00

  • Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

    abstract::The combination of imatinib with chemotherapy has been recently reported as very promising in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). During 2004 and 2005, 45 patients with newly diagnosed Ph+ ALL were treated in the Group for Research on Adult Acute Lymphoblastic Leuke...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-03-011908

    authors: de Labarthe A,Rousselot P,Huguet-Rigal F,Delabesse E,Witz F,Maury S,Réa D,Cayuela JM,Vekemans MC,Reman O,Buzyn A,Pigneux A,Escoffre M,Chalandon Y,MacIntyre E,Lhéritier V,Vernant JP,Thomas X,Ifrah N,Dombret H,Group

    更新日期:2007-02-15 00:00:00

  • Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.

    abstract::The deregulated Bcr/Abl tyrosine kinase is responsible for the development of Philadelphia (Ph)-positive leukemia in humans. To investigate the significance of the C-terminal Abl actin-binding domain within Bcr/Abl p190 in the development of leukemia/lymphoma in vivo, mutant p190 DNA constructs were used to generate t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Heisterkamp N,Voncken JW,Senadheera D,Gonzalez-Gomez I,Reichert A,Haataja L,Reinikainen A,Pattengale PK,Groffen J

    更新日期:2000-09-15 00:00:00

  • Identification of human lymphoma cells by antisera to malignancy-associated nucleolar antigens.

    abstract::The non-Hodgkin's lymphomas (NHL) are a diverse group of human lymphoid neoplasms that have long presented pathologists with formidable diagnostic challenges. These tumors of the immune system are thought to represent neoplastic transformations of most of the recognized stages in T and B lymphocyte ontogeny. Lymphoma ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ford RJ,Cramer M,Davis FM

    更新日期:1984-03-01 00:00:00

  • Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive disease characterized by lung endothelial dysfunction and vascular remodeling. Recently, bone marrow progenitor cells have been localized to PAH lungs, raising the question of their role in disease progression. Independently, serotonin (5-HT) and its receptors hav...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-358374

    authors: Launay JM,Hervé P,Callebert J,Mallat Z,Collet C,Doly S,Belmer A,Diaz SL,Hatia S,Côté F,Humbert M,Maroteaux L

    更新日期:2012-02-16 00:00:00

  • Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia.

    abstract::Chromosome 11q deletions are frequently observed in chronic lymphocytic leukemia (CLL) in association with progressive disease and a poor prognosis. A minimal region of deletion has been assigned to 11q22-q23. Trinucleotide repeats have been associated with anticipation in disease, and evidence of anticipation has bee...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.2.509

    authors: Auer RL,Jones C,Mullenbach RA,Syndercombe-Court D,Milligan DW,Fegan CD,Cotter FE

    更新日期:2001-01-15 00:00:00

  • HIV gene therapy research advances.

    abstract::In this issue of Blood, Tebas et al report antiviral effects in a clinical trial of multiple infusions of lentiviral vector–modified autologous CD4T lymphocytes in 17 HIV-infected patients aviremic on antiretroviral therapy (ART). ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-01-475921

    authors: Jacobson JM

    更新日期:2013-02-28 00:00:00

  • B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging.

    abstract::Aging is associated with a decline in B-lymphopoiesis in the bone marrow and accumulation of long-lived B cells in the periphery. These changes decrease the body's ability to mount protective antibody responses. We show here that age-related changes in the B lineage are mediated by the accumulating long-lived B cells....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-307983

    authors: Keren Z,Naor S,Nussbaum S,Golan K,Itkin T,Sasaki Y,Schmidt-Supprian M,Lapidot T,Melamed D

    更新日期:2011-03-17 00:00:00

  • High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

    abstract::Transforming mutations in NRAS and KRAS are thought to play a causative role in the development of numerous cancers, including myeloid malignancies. Although mutations at amino acids 12, 13, or 61 account for the majority of oncogenic Ras variants, we hypothesized that less frequent mutations at alternate residues may...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-152157

    authors: Tyner JW,Erickson H,Deininger MW,Willis SG,Eide CA,Levine RL,Heinrich MC,Gattermann N,Gilliland DG,Druker BJ,Loriaux MM

    更新日期:2009-02-19 00:00:00

  • Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.

    abstract::BMS-354825 (dasatinib) and AMN107 (nilotinib) are potent alternate Abl inhibitors with activity against many imatinib mesylate-resistant BCR-ABL kinase domain (KD) mutants, except T315I. We used N-ethyl-N-nitrosourea (ENU)-exposed Ba/F3-p210(BCR-ABL) cells to compare incidence and types of KD mutants emerging in the p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-004580

    authors: Bradeen HA,Eide CA,O'Hare T,Johnson KJ,Willis SG,Lee FY,Druker BJ,Deininger MW

    更新日期:2006-10-01 00:00:00

  • Gamma heavy chain disease: clinical aspects and characterization of a deleted, noncovalently linked gamma1 heavy chain dimer (BAZ).

    abstract::This report describes the clinical and immunoglobulin features of a patient with gamma heavy chain disease (HCD), who presented with a clinical picture suggestive of an underlying malignancy rather than the usual picture of lymphoma or granulomatous disease. A unique clinical feature was the nearly total replacement o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Faguet GB,Barton BP,Smith LL,Garver FA

    更新日期:1977-04-01 00:00:00

  • Receptor-specific inhibition of bone marrow erythropoiesis by recombinant DNA-derived interleukin-2.

    abstract::Interleukin-2 (IL-2) induces differential secretion of lymphokines by IL-2 receptor (IL-2R)-positive and IL-2R-negative T cells. We studied T cell IL-2R-specific modulation of adult bone marrow erythropoiesis by recombinant IL-2 (rIL-2). I3-2R were induced by CD3 T cell surface determinant-triggering and analyzed by c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Burdach SE,Levitt LJ

    更新日期:1987-05-01 00:00:00

  • Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133.

    abstract::AC133 is a member of a novel family of cell surface proteins with 5 transmembrane domains. The function of AC133 is unknown. Although AC133 mRNA is detected in different tissues, its expression in the hematopoietic system is restricted to CD34+ stem cells. AC133 is also expressed on stem cells of other tissues, includ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-06-1881

    authors: Shmelkov SV,Jun L,St Clair R,McGarrigle D,Derderian CA,Usenko JK,Costa C,Zhang F,Guo X,Rafii S

    更新日期:2004-03-15 00:00:00

  • Relation of autonomous and interleukin-2-responsive growth of leukemic cells to survival in adult T-cell leukemia.

    abstract::We examined autonomous and interleukin-2 (IL-2)-responsive growth activities of leukemic cells derived from peripheral blood, as well as several clinical manifestations, including serum lactate dehydrogenase (LDH) level, of 35 patients with adult T-cell leukemia (ATL) to determine whether these properties were related...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arima N,Hidaka S,Fujiwara H,Matsushita K,Ohtsubo H,Arimura K,Kukita T,Fukumori J,Tanaka H

    更新日期:1996-04-01 00:00:00

  • Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation.

    abstract::Anemia and vitamin D deficiency are conditions that both result in significant morbidity and increase with age. The potential relationship between them remains poorly understood, particularly in the elderly. We used the Third National Health and Nutrition Examination Survey to examine the association of vitamin D defi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-309708

    authors: Perlstein TS,Pande R,Berliner N,Vanasse GJ

    更新日期:2011-03-10 00:00:00

  • Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia.

    abstract::We studied the effects of interleukin-4 (IL-4) and IL-6 on the growth of leukemic blasts from 40 patients with acute myelogenous leukemia (AML). Patients were selected on the basis of negativity for a series of B-cell antigens including CD10 and CD19. Twenty-one cases were CD34-positive (CD34+) (greater than 15% of bl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Akashi K,Harada M,Shibuya T,Eto T,Takamatsu Y,Teshima T,Niho Y

    更新日期:1991-07-01 00:00:00

  • Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo.

    abstract::Although plasmacytoid dendritic cells (pDCs) are involved in HIV-1 pathogenesis, the precise mechanism of interaction between pDCs and HIV-1 in vivo is not clear. The conflicting reports in HIV-1-infected patients highlight the importance of studying the interaction between HIV-1 and pDCs in relevant in vivo models. T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-331173

    authors: Zhang L,Jiang Q,Li G,Jeffrey J,Kovalev GI,Su L

    更新日期:2011-06-09 00:00:00

  • BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.

    abstract::An inverse relationship between BCL-2 expression and cell cycle transition has been suggested by recent studies in murine models. To investigate the clinical relevance of these laboratory studies, a group of 116 paraffin-embedded non-Hodgkin's lymphoma (NHL) biopsy specimens (Working Formulation Groups D-H, and J) fro...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Winter JN,Andersen J,Reed JC,Krajewski S,Variakojis D,Bauer KD,Fisher RI,Gordon LI,Oken MM,Jiang S,Jeffries D,Domer P

    更新日期:1998-02-15 00:00:00

  • Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

    abstract::Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

    更新日期:1995-08-01 00:00:00

  • The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

    abstract::The development of inhibitory antibodies to factor VIII in patients affected by a mild form of hemophilia A (factor VIII > 0.05 IU/mL) is considered a rare event. In this study, we evaluated the relationship between genotype and anti-factor VIII antibody formation in a patient with mild hemophilia A. Mutation analysis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fijnvandraat K,Turenhout EA,van den Brink EN,ten Cate JW,van Mourik JA,Peters M,Voorberg J

    更新日期:1997-06-15 00:00:00

  • Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction.

    abstract::BCL3 encodes a protein with close homology to IkappaB proteins and interacts with p50 NF-kappaB homodimers. However, the regulation and transcriptional activity of BCL3 remain ill-defined. We observed here that interleukin-9 (IL-9) and IL-4, but not IL-2 or IL-3, transcriptionally upregulated BCL3 expression in T cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richard M,Louahed J,Demoulin JB,Renauld JC

    更新日期:1999-06-15 00:00:00